Farmavita.Net member is developing innovative concept for glogal branding and distribution of remedies and devices for therapy of arthritis.
Company is looking to joint-venture, collaborative development or in-licensing of non-prescrition products, on exclusive basis.
For more details please contact Farmavita.Net.
Farmavita.Net member has developed technology which enables development of oral dosage forms with controlled and site specific release of active pharmaceutical ingredients. Patent pending application.
Company is looking for following types of cooperation:
- Joint-venture and private equity partners
- Collaborative product development
- Consulting or contract research contracts
WE REQUIRE PLANT PROVEN COMMERCIAL TECHNOLOGY TO MANAUFACTURE SPECTINOMYCIN HCL IN INDIA . TECHNOLOGY LICENCENSORS/MANUFACTURING COMPANIES/CONSULTANTS TO SUBMIT THEIR TECHNICAL AND COMMERCIAL PROFILE AND BUSINESS TERMS.
CONTACT; MR.ARVIND GANDHI -GM MKTG ( API AND FINE CHEMICALS) ASENCE PHARMA PVT.LTD.,MUMBAI.
The gradual spread of software automation in drug development may be getting a boost from open source systems. Most e-clinical systems today--from data capture and storage to trial management and operations--are proprietary, despite the excellent work that solutions providers have done to make their products compatible with existing standards-based and de facto standard industry systems.
Micro- and nanoscale technologies are emerging as powerful enabling tools for tissue engineering and drug discovery. In tissue engineering, micro- and nanotechnologies can be used to fabricate biomimetic scaffolds with increased complexity and vascularization.
The whole 16 pages article is available for download at Downloads section of Farmavita.Net.
7-8 July 2014, London, UK
The global lyophilisation for pharmaceuticals products and services market will reach $3.09bn in 2014 with revenues showing strong growth to 2024. With increasing numbers of proteins being discovered, the importance of lyophilisation is coming to the fore, for example, as a means of extending the shelf life of pharmaceutical and biopharmaceutical products.
This report gives a thorough analysis of the refurbished medical devices market segment. The regulatory environment for refurbished devices is assessed in 92 countries. Opportunities within this market are assessed by device type and by country. A thorough analysis of who the end users for refurbished devices are and what their demands are, with strategies and best practices for growth discussed.
Monitoring Downloads Section
You can easily monitor all new articles and reports published at Downloads Section of Farmavita.Net. Click on the RSS button and bookmark this RSS feed. RSS button is located beside title “Farmavita.Net - Pharmaceutical Licensing Network :: File Repository“.